BCAL Diagnostics has secured a seat on Genetic Signatures' board, though it is only part of what it asked for. At an ...

AusBiotech says the Government's R&D tax bill still penalises the clinical trial and manufacturing companies Australia most ...

The Melbourne company dosed the first patient in its Beyond Harmony study of NTI164 on 21 September. All six sites across ...

Melbourne biotech Magellan Stem Cells is 17 years old and about to begin a pivotal Phase 3 trial of its stem cell treatment ...

Neurizon Therapeutics has finished enrolling its pivotal ALS trial ahead of schedule. The US Food and Drug Administration has ...

Nyrada has raised $0.73 million before costs through a Securities Purchase Plan (SPP), topping up funds from its September ...

Immuron says its travellers' diarrhoea tablet, Travelan, has overtaken Imodium in total Australian pharmacy sales over the ...

Australia's biotechnology sector has just had its biggest gathering yet. Australia's Biggest Week in Biotech 2026 drew 2,019 ...

A Greek study of an Australian-developed radioactive implant found that tumours stopped growing in every patient assessed at ...

Dr Brian McNamee AO will retire from CSL's board in March next year, and Gordon Naylor, who has served as Interim CEO and ...

"Most people can't conceive what daily life is like for a person living with Prader-Willi syndrome," said Kathlene Jones, CEO ...

BioNTech has opened its clinical-scale mRNA manufacturing and research facility at La Trobe University's Bundoora campus, ...